DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies
1985

DNA Index of Ovarian Carcinomas

Sample size: 56 publication Evidence: moderate

Author Information

Author(s): E. Erbal, M. Vaghil, S. Pepe', G. Amato', M. Bistolfil, P. Ubeziol, C. Mangioni, F. Landoni, L. Morascal

Primary Institution: Istituto di Ricerche Farmacologiche 'Mario Negri'

Hypothesis

To describe the DNA index in ovarian cancers and its correlation with the cytological degree of malignancy.

Conclusion

Ovarian carcinomas show a large difference in DNA index between patients, with DNA aneuploid cells clustering in the highest grade of malignancy.

Supporting Evidence

  • 24 patients had a diploid DNA index (1.0) while others ranged from 1.2 to 2.0.
  • Primary culture was successful in 57% of the tumours, especially in DNA aneuploid tumours.
  • The mean S-phase for tumours with a DNA index of 1.0 was 3.5% and 14.1% for those with DNA index >1.

Takeaway

This study looked at the DNA of ovarian cancer cells from patients and found that some had normal DNA while others had more complex DNA, which could help understand how aggressive the cancer is.

Methodology

Flow cytometric analysis was used to measure the DNA content and cell cycle distribution of ovarian cancer cells obtained from various sources.

Potential Biases

Potential bias due to the low proportion of samples suitable for analysis and the presence of normal cells in the suspensions.

Limitations

Only 43% of samples were suitable for flow cytometry, and the study may overestimate the frequency of DNA aneuploidy.

Participant Demographics

Patients with ovarian cancer classified by FIGO staging as III and IV.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication